{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:03:57Z","timestamp":1791144237830,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Early Human Development"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.earlhumdev.2005.02.002","type":"journal-article","created":{"date-parts":[[2005,6,10]],"date-time":"2005-06-10T15:55:01Z","timestamp":1118418901000},"page":"647-654","source":"Crossref","is-referenced-by-count":40,"title":["Transfer of antivirals across the human placenta"],"prefix":"10.1016","volume":"81","author":[{"given":"Gian Maria","family":"Pacifici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.earlhumdev.2005.02.002_bib1","first-page":"609","article-title":"Perinatal acquired human immunodeficiency virus infection","volume":"9","author":"Oxtoby","year":"1990","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib2","unstructured":"World Health Organisation Global Programme on AIDS: current and future dimension of the HIV\/AIDS pandemic: a capsule summary. Geneva WHO; January 1992."},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1068-607X(95)00062-N","article-title":"HIV infection in women","volume":"3","author":"Duff","year":"1996","journal-title":"Prim Care Update Ob Gyns"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib4","first-page":"S33","article-title":"Perinatal HIV-1 transmission: recent advances and therapeutic interventions","volume":"10","author":"Bryson","year":"1996","journal-title":"AIDS"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/oxfordjournals.epirev.a017922","article-title":"Mother-to-child transmission of HIV","volume":"18","author":"John","year":"1996","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib6","unstructured":"Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. December 17, 1994. From the internet: http:\/\/aidsinfo.nih.gov."},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib7","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00006454-200207000-00012","article-title":"Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina","volume":"21","author":"Fiscus","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib8","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1056\/NEJM200010053431401","article-title":"A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators","volume":"343","author":"Lallemant","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib9","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa991159","article-title":"Antiretroviral therapy during pregnancy and the risk of an adverse outcome","volume":"346","author":"Tuomala","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib10","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal\u2013infant transmission of human immunodeficiency virus type 1 with zidovudine treatment","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00002030-200104130-00012","article-title":"HIV-infected pregnant women and vertical transmission in Europe since 1986","volume":"15","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib12","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1001\/jama.285.16.2083","article-title":"Agence Nationale de Recherches sur le SIDA (ANRS) 075 Group. Lamivudine\u2013zidovudine combination for prevention of maternal\u2013infant transmission of HIV-1","volume":"285","author":"Mandelbrot","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1749-6632.2000.tb05498.x","article-title":"Antiretroviral pharmacology in pregnant women and their newborns","volume":"918","author":"Mirochnick","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0889-8545(03)00089-5","article-title":"Antiviral and antiretrovirals use in pregnancy","volume":"30","author":"Money","year":"2003","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/00003088-199528030-00005","article-title":"Placental transfer of drugs administered to the mother","volume":"28","author":"Pacifici","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib16","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/0002-9378(72)90909-X","article-title":"Transfer across the perfused human placenta of antipyrine, sodium and leucine","volume":"114","author":"Schneider","year":"1972","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib17","first-page":"246","article-title":"Human and dual placenta perfusion\u2014criteria for toxicity evaluations","volume":"3B","author":"Miller","year":"1993","journal-title":"Methods Toxicol"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000410672","article-title":"Human placenta in vitro: characterisation during 12 hours of dual perfusion","volume":"13","author":"Miller","year":"1985","journal-title":"Contrib Gynecol Obstet"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000410667","article-title":"Criteria for evaluating perfusing experiments and presentation of the results","volume":"13","author":"Challier","year":"1985","journal-title":"Contrib Gynecol Obstet"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib20","series-title":"Goodman and Gilman's the pharmacological basis of therapeutics","first-page":"1313","article-title":"Antiviral agents","author":"Hayden","year":"2001"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib21","series-title":"Goodman and Gilman's the pharmacological basis of therapeutics","first-page":"1349","article-title":"Antiretroviral agents","author":"Raffanti","year":"2001"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib22","series-title":"Goodman and Gilman's the pharmacological basis of therapeutics","first-page":"1917","article-title":"Design and optimization of dosage regimens: pharmacokinetic data","author":"Thummel","year":"2001"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0002-9378(99)70175-4","article-title":"In vitro models to predict the in vivo mechanism, rate, and extent of placental transfer of dideoxynucleotide drug against human immunodeficiency virus","volume":"180","author":"Tuntland","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ajog.2004.01.034","article-title":"Maternal fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with immunodeficiency virus","volume":"191","author":"Chappuy","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib25","first-page":"885","article-title":"Acyclovir transport by the human placenta","volume":"120","author":"Henderson","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib26","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0002-9378(94)70089-3","article-title":"The transfer of the nucleoside analogue ganciclovir across the perfused human placenta","volume":"170","author":"Gilstrap","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00000441-199309000-00004","article-title":"Ganciclovir transfer by human placenta and its effects on rat fetal cells","volume":"306","author":"Henderson","year":"1993","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib28","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/0002-9378(92)91742-S","article-title":"The transfer of anti-human immunodeficiency virus nucleoside compounds by the term human placenta","volume":"167","author":"Bawdon","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2125.1994.tb04347.x","article-title":"Transfer of didanosine across the human placenta","volume":"38","author":"Henderson","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib30","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00126334-200304010-00006","article-title":"Exposure to antiviral therapy in utero or early life: the heath of uninfected children born to HIV-infected women","volume":"32","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00007691-200404000-00004","article-title":"Safety and pharmacokinetics of antiretroviral therapy during pregnancy","volume":"26","author":"Rakhmanina","year":"2004","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib32","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/0140-6736(91)90313-E","article-title":"Fetoplacental passage of 2\u2032,3\u2032-dideoxyinosine","volume":"337","author":"Pons","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib33","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1128\/AAC.48.11.4332-4336.2004","article-title":"Maternal\u2013fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant women","volume":"48","author":"Chappuy","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1086\/515641","article-title":"Pharmacokinetics of nevirapine in human immunodeficiency virus type 1 infected pregnant women and their neonates","volume":"178","author":"Mirochnick","year":"1998","journal-title":"J Inf Disp"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib35","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00002030-200204120-00008","article-title":"Transplacental passage of protease inhibitors at delivery","volume":"16","author":"Marzolini","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib36","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJM199611283352201","article-title":"Maternal viral load, zidovudine treatment, and risk of transmission of human immunodeficiency virus type 1 from mother to infant","volume":"335","author":"Sperling","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/infdis\/161.2.203","article-title":"Transfer of zidovudine (AZT) by human placenta","volume":"161","author":"Liebes","year":"1990","journal-title":"J Inf Disp"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib38","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/00006454-200209000-00010","article-title":"Concentration of protease inhibitors in cord blood after in utero exposure","volume":"21","author":"Mirochnick","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000441-199001000-00005","article-title":"Azidothymidine (zidovudine) transport by the human placenta","volume":"299","author":"Schenker","year":"1990","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000292432","article-title":"The ex vivo transfer of the anti-HIV nucleoside compound d4T in the human placenta","volume":"38","author":"Bawdon","year":"1994","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0002-9378(97)70487-3","article-title":"The maternal\u2013fetal transfer of lamivudine in the ex vivo human placenta","volume":"176","author":"Bloom","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib42","first-page":"244","article-title":"The ex vivo human placental transfer of the anti-HIV nucleoside abacavir and the protease inhibitor amprenavir","volume":"6","author":"Bawdon","year":"1998","journal-title":"Inf Dis Obstet Gynecol"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib43","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0002-9378(95)90089-6","article-title":"The maternal\u2013fetal transfer of bisheteroypiperazine (U-87201-E) in the ex vivo human placenta","volume":"172","author":"Roberts","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib44","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1067\/mob.2001.113319","article-title":"Maternal\u2013fetal transfer of saquinavir studied in the ex vivo placental perfusion model","volume":"185","author":"Forestier","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib45","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0002-9378(98)70078-X","article-title":"Placental transfer of ritonavir with zidovudine in the ex vivo placental perfusion model","volume":"179","author":"Casey","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib46","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1128\/AAC.37.6.1232","article-title":"Experimental study of transplacental passage of alpha interferon by two assay techniques","volume":"37","author":"Waysbort","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib47","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0002-9378(11)90791-1","article-title":"The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082)","volume":"168","author":"O'Sullivan","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0140-6736(89)90449-2","article-title":"Fetoplacental passage of zidovudine","volume":"ii","author":"Gillet","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0028-2243(91)90122-2","article-title":"Placental passage of azathiothymidine (AZT) during the second trimester of pregnancy: study by direct fetal blood sampling under ultrasound","volume":"40","author":"Pons","year":"1991","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib50","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00002030-200003310-00006","article-title":"Oral zidovudine during labour to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood","volume":"14","author":"Bhadrakom","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib51","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1067\/mob.2001.108344","article-title":"Maternal\u2013fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women","volume":"184","author":"Mandelbrot","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.earlhumdev.2005.02.002_bib52","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0002-9378(11)80023-2","article-title":"Pharmacokinetics of acyclovir in the term human pregnancy and neonate","volume":"164","author":"Frenkel","year":"1991","journal-title":"Am J Obstet Gynecol"}],"container-title":["Early Human Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378205000599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378205000599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T19:25:18Z","timestamp":1550949918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378378205000599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0378378205000599"],"URL":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2005.02.002","relation":{},"ISSN":["0378-3782"],"issn-type":[{"value":"0378-3782","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}